STOCK TITAN

Definitive Healthcare Corp. - DH STOCK NEWS

Welcome to our dedicated page for Definitive Healthcare news (Ticker: DH), a resource for investors and traders seeking the latest updates and insights on Definitive Healthcare stock.

Definitive Healthcare Corp. (NASDAQ: DH) is a leading provider of healthcare commercial intelligence, specializing in delivering comprehensive data and analytics on healthcare providers and their activities. The company’s suite of solutions offers clients access to the most accurate and detailed information available, covering over 8,100 hospitals and Integrated Delivery Networks (IDNs), 7,300 ambulatory surgery centers, 11,000 imaging centers, 38,000 long-term care facilities, 1,200 Accountable Care Organizations (ACOs) and Health Information Exchanges (HIEs), 197,000 physician groups, 1.3 million physicians, and 750 Canadian hospitals.

Definitive Healthcare's robust data set helps organizations in the healthcare sector optimize everything from product development to go-to-market planning, and sales and marketing execution. Backed by Spectrum Equity, the company is committed to transforming data, analytics, and expertise into actionable healthcare commercial intelligence.

The company continually invests in enhancing its product offerings and expanding its data coverage. Recent achievements include a 14% year-over-year revenue growth in the third quarter, reaching $65.3 million. Additionally, Definitive Healthcare has forged strategic partnerships, such as the recent collaboration with VML Health to streamline engagement between pharmaceutical companies and Key Opinion Leaders (KOLs), leveraging the Monocl ExpertInsight platform.

Definitive Healthcare’s competitive edge lies in its ability to provide unparalleled insights into the healthcare provider market, which equips its clients with the necessary tools to identify and capitalize on new opportunities. The company’s platform supports clients in uncovering the right markets, opportunities, and individuals, thereby shaping the future of healthcare. With the majority of its revenue derived from the United States, Definitive Healthcare continues to be a pivotal player in the healthcare data analytics industry.

For more information, visit www.definitivehc.com.

Rhea-AI Summary
Definitive Healthcare Corp. reported a 9% increase in fourth-quarter revenue to $65.9 million and a 13% increase in full-year revenue to $251.4 million in 2023. The company also announced customer wins and financial guidance for 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.48%
Tags
-
Rhea-AI Summary
Definitive Healthcare Corp. will report financial results for Q4 and full year 2023 on February 28, 2024. The company will host a conference call to discuss the results. Investors can access the live webcast or dial-in for the call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.76%
Tags
-
Rhea-AI Summary
Definitive Healthcare (Nasdaq: DH) announced the appointment of Jason Krantz as interim CEO, following the departure of Robert Musslewhite. The company reaffirmed its Q4 2023 financial guidance and issued preliminary guidance for 2024, expecting revenue to grow 5-7% and adjusted EBITDA margin to increase by approximately 200 basis points. The leadership transition aims to position the organization for further growth, with Mr. Krantz expressing confidence in the company's potential for long-term value creation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.58%
Tags
none
Rhea-AI Summary
Datassential's former CEO, Jim Emling, has been appointed Executive Chair of the Board of Directors at VBA, a company heavily investing in sales and product development after closing a growth equity transaction led by Spectrum Equity and Arthur Ventures. VBA serves the entire payer landscape, including third party administrators (TPAs) and health plans, with its next-gen Core Administrative Processing System, user engagement platforms, customer support tools, population health reporting solution, and robust data connections.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
-
Rhea-AI Summary
Definitive Healthcare has announced the hiring of Carrie Lazorchak as its new Chief Revenue Officer. As part of her employment agreement, Lazorchak has been granted 385,695 time-based restricted stock units (RSUs) effective November 1, 2023. The RSUs will vest over a 4-year period, with 25% vesting on the 1-year anniversary of the grant date and the remainder vesting in quarterly installments over the subsequent 3 years.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.03%
Tags
none
-
Rhea-AI Summary
Definitive Healthcare Corp. reported a 14% year-over-year increase in revenue for the third quarter, reaching $65.3 million. The net loss was ($248.7) million, compared to ($6.9) million in the same period last year. Adjusted Net Income and Adjusted EBITDA also showed improvement, reaching $14.6 million and $21.7 million, respectively. The company's cash flow from operations was $9.5 million in the quarter, while unlevered free cash flow was $17.7 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.97%
Tags
Rhea-AI Summary
Definitive Healthcare Corp. will report financial results for its third quarter ended September 30, 2023, on November 2, 2023. The company will host a conference call and webcast to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.5%
Tags
-
Rhea-AI Summary
Definitive Healthcare announces Carrie Lazorchak as Chief Revenue Officer
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.77%
Tags
none
-
Rhea-AI Summary
Definitive Healthcare Corp. announces changes to its Board of Directors. Scott Stephenson joins the Board and nominating committee, while Chris Mitchell steps down. Stephenson's expertise in data and analytics will benefit the company's SaaS platform and AI-driven solutions. No concrete positive or negative impacts on stock price identified.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.35%
Tags
management
Rhea-AI Summary
Definitive Healthcare grants inducement awards to former employees of Populi, Inc. as part of acquisition
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.35%
Tags
none

FAQ

What is the current stock price of Definitive Healthcare (DH)?

The current stock price of Definitive Healthcare (DH) is $4.37 as of November 22, 2024.

What is the market cap of Definitive Healthcare (DH)?

The market cap of Definitive Healthcare (DH) is approximately 514.7M.

What services does Definitive Healthcare Corp. provide?

Definitive Healthcare provides comprehensive healthcare commercial intelligence, including detailed data and analytics on hospitals, physicians, and other healthcare providers.

How does Definitive Healthcare’s data benefit its clients?

The data helps clients with product development, go-to-market planning, and sales and marketing execution by providing accurate, comprehensive information on healthcare providers.

What is the geographic focus of Definitive Healthcare’s revenue?

Definitive Healthcare derives the majority of its revenue from the United States.

Who backs Definitive Healthcare Corp.?

Definitive Healthcare is backed by Spectrum Equity.

What recent financial achievement has Definitive Healthcare reported?

Definitive Healthcare reported a 14% year-over-year growth in third quarter revenue, reaching $65.3 million.

What recent partnerships has Definitive Healthcare formed?

Definitive Healthcare recently partnered with VML Health to streamline engagement between pharmaceutical companies and Key Opinion Leaders (KOLs) using the Monocl ExpertInsight platform.

What types of healthcare providers are included in Definitive Healthcare’s data?

The data includes information on hospitals, IDNs, ambulatory surgery centers, imaging centers, long-term care facilities, ACOs, HIEs, physician groups, and more.

How does Definitive Healthcare stay competitive in the market?

Definitive Healthcare continually invests in enhancing its product offerings and expanding data coverage to provide the most comprehensive and accurate information available.

What is the Monocl ExpertInsight platform used for?

The Monocl ExpertInsight platform delivers medical research and clinical activity data on millions of medical experts globally, helping pharmaceutical companies engage with KOLs more effectively.

Where can I find more information about Definitive Healthcare?

For more information, visit the company’s website at www.definitivehc.com.

Definitive Healthcare Corp.

Nasdaq:DH

DH Rankings

DH Stock Data

514.65M
46.65M
3.91%
93.14%
2.35%
Health Information Services
Services-prepackaged Software
Link
United States of America
FRAMINGHAM